Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation

Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical therapy does not ameliorate this risk. Liver transplantation offers the most effective option to reduce circulating levels of low-density lipoprote...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical lipidology Vol. 13; no. 6; pp. 880 - 886
Main Authors Cephus, Constance E., Qureshi, Athar M., Sexson Tejtel, S. Kristen, Alam, Mahboob, Moodie, Douglas S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2019
Subjects
Angiogram
Cardiac catheterization
Coronary atherosclerosis
Genetic
LDL receptor
Liver transplantation
Pediatric
Regression
Treatment
Cardiac catheterization
Treatment
Coronary atherosclerosis
Regression
Genetic
Angiogram
Pediatric
Liver transplantation
LDL receptor
Online AccessGet full text

Cover

Abstract Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical therapy does not ameliorate this risk. Liver transplantation offers the most effective option to reduce circulating levels of low-density lipoprotein cholesterol and thereby reduce risk of cardiovascular events. Angiographic evidence of regression of coronary artery disease is presented. •Current therapy for homozygous FH does not result in persistently normal LDL-c levels.•Contrast cCTA may provide a reliable assessment of atherosclerosis.•Study of QOL during apheresis and after liver transplantation in children is needed.•Coronary artery atherosclerosis may regress after liver transplantation.
AbstractList Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical therapy does not ameliorate this risk. Liver transplantation offers the most effective option to reduce circulating levels of low-density lipoprotein cholesterol and thereby reduce risk of cardiovascular events. Angiographic evidence of regression of coronary artery disease is presented.
Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical therapy does not ameliorate this risk. Liver transplantation offers the most effective option to reduce circulating levels of low-density lipoprotein cholesterol and thereby reduce risk of cardiovascular events. Angiographic evidence of regression of coronary artery disease is presented. •Current therapy for homozygous FH does not result in persistently normal LDL-c levels.•Contrast cCTA may provide a reliable assessment of atherosclerosis.•Study of QOL during apheresis and after liver transplantation in children is needed.•Coronary artery atherosclerosis may regress after liver transplantation.
Author Cephus, Constance E.
Alam, Mahboob
Moodie, Douglas S.
Sexson Tejtel, S. Kristen
Qureshi, Athar M.
Author_xml – sequence: 1
  givenname: Constance E.
  surname: Cephus
  fullname: Cephus, Constance E.
  email: cecephus@texaschildrens.org, Cephus@bcm.edu, cecephus@att.net
  organization: Texas Children's Hospital Heart Center, Pediatric Cardiology, Houston, TX
– sequence: 2
  givenname: Athar M.
  surname: Qureshi
  fullname: Qureshi, Athar M.
  organization: Texas Children's Hospital Heart Center, Pediatric Cardiology, Houston, TX
– sequence: 3
  givenname: S. Kristen
  surname: Sexson Tejtel
  fullname: Sexson Tejtel, S. Kristen
  organization: Texas Children's Hospital Heart Center, Pediatric Cardiology, Houston, TX
– sequence: 4
  givenname: Mahboob
  surname: Alam
  fullname: Alam, Mahboob
  organization: Margaret M and Albert B Alkek Department of Medicine, Cardiology, Baylor College of Medicine, Houston, TX
– sequence: 5
  givenname: Douglas S.
  surname: Moodie
  fullname: Moodie, Douglas S.
  organization: Texas Children's Hospital Heart Center, Pediatric Cardiology, Houston, TX
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31704104$$D View this record in MEDLINE/PubMed
BookMark eNp9UMtqHDEQFMEhfiQ_kEPQMZfZ6DEjzYRcwpIXGAzGOQut1PJo0Yw20qydzdenl3VyNDQqIVUVXXVJzuY8AyFvOVtxxtWH7WprXVoJxocVw2H6BbngvVZNq_vhDO-DlI3odXtOLmvdMtZ1mnWvyLnkmrWctRfk9zqXPNtyoLYsgOBjBVuBxpla6saYPH2My0jHPOU_h_u8rzTYKaZoEx0POyhuzAkqahGmaD_SW7gvUGvM6BDwnab4gOdS7Fx3yc6LXfDvNXkZbKrw5gmvyM-vX-7W35vrm28_1p-vGyc7tTSboAIM3CophVRuY0UXGHAHXrVCwqCUHJTw0ikZvGOtk7LzXPieh6CZ3sgr8v7kuyv51x4XNVOsDhIuAhjGCMlR0rNeIVWcqK7kWgsEsytxwm4MZ-bYuNmaY-Pm2LhhOEyj6N2T_34zgf8v-VcxEj6dCIApHyIUU12EGRPEAm4xPsfn_P8CpOCXAQ
CitedBy_id crossref_primary_10_1097_MOL_0000000000000853
crossref_primary_10_1016_j_transproceed_2023_02_024
crossref_primary_10_1016_j_atherosclerosis_2024_117525
crossref_primary_10_3390_medicina58101430
crossref_primary_10_1093_eurheartj_ehad197
crossref_primary_10_5551_jat_RV17050
crossref_primary_10_1038_s41569_023_00892_0
crossref_primary_10_3389_fped_2020_567895
Cites_doi 10.1186/1477-7525-8-150
10.1016/j.atherosclerosis.2007.08.017
10.1016/j.jacl.2018.05.007
10.1016/j.jacl.2019.03.001
10.1111/j.1399-0012.2007.00764.x
10.1016/j.amjcard.2008.07.035
10.1093/eurheartj/eht015
10.1016/j.jacl.2018.10.011
10.1016/j.jacl.2019.02.001
10.1016/j.amjcard.2016.05.042
10.1111/chd.12301
10.1161/CIRCULATIONAHA.113.001292
10.1016/j.jacc.2017.06.058
10.1016/S2213-8587(17)30044-X
10.1016/j.jacc.2013.07.081
10.1016/j.jacl.2015.12.009
10.1002/lt.24696
10.1016/j.atherosclerosis.2019.04.219
10.1007/s40265-019-01114-z
10.1056/NEJM198412273112603
10.1016/j.ijcard.2014.09.058
10.1080/14656566.2018.1550071
10.1007/s40119-015-0037-z
10.1016/S0021-9150(99)00109-4
10.1016/j.jacl.2015.05.001
10.1016/j.atherosclerosis.2016.02.009
10.1007/s11883-014-0482-5
10.1093/eurheartj/ehu274
10.1016/S0140-6736(10)60284-X
10.1161/CIRCULATIONAHA.111.042523
10.1093/eurheartj/ehv157
10.1016/S0022-3476(82)80579-9
10.1016/S0140-6736(14)61374-X
ContentType Journal Article
Copyright 2019 National Lipid Association
Copyright © 2019 National Lipid Association. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2019 National Lipid Association
– notice: Copyright © 2019 National Lipid Association. Published by Elsevier Inc. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jacl.2019.09.007
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1876-4789
EndPage 886
ExternalDocumentID 10_1016_j_jacl_2019_09_007
31704104
S193328741930279X
Genre Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
M41
MO0
N9A
O-L
O9-
OA.
OAUVE
OL~
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
Z5R
~G-
AAXKI
AFJKZ
AKRWK
NPM
AAYXX
ACRPL
ADNMO
CITATION
7X8
ID FETCH-LOGICAL-c356t-bf6fe91a633236cba25f0e1ced6423e9663962d3c63fdc04c335d12d81ff707b3
IEDL.DBID .~1
ISSN 1933-2874
IngestDate Wed Dec 04 11:56:16 EST 2024
Fri Dec 06 01:08:02 EST 2024
Sat Sep 28 08:28:14 EDT 2024
Fri Feb 23 02:48:38 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Cardiac catheterization
Treatment
Coronary atherosclerosis
Regression
Genetic
Angiogram
Pediatric
Liver transplantation
LDL receptor
Language English
License Copyright © 2019 National Lipid Association. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c356t-bf6fe91a633236cba25f0e1ced6423e9663962d3c63fdc04c335d12d81ff707b3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
PMID 31704104
PQID 2313358086
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2313358086
crossref_primary_10_1016_j_jacl_2019_09_007
pubmed_primary_31704104
elsevier_sciencedirect_doi_10_1016_j_jacl_2019_09_007
PublicationCentury 2000
PublicationDate 2019-11-01
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical lipidology
PublicationTitleAlternate J Clin Lipidol
PublicationYear 2019
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Raal, Hovingh, Blom (bib18) 2017; 5
Luirink, Kuipers, Hutten (bib29) 2019; 285
Raal, Honarpour, Blom (bib19) 2015; 385
Gaudet, Langslet, Gidding (bib20) 2018; 12
Santos, Miname, Martinez (bib28) 2008; 197
Parmar, Vandriel, Ng (bib33) 2017; 23
Roeters van Lennep, Averna, Alonso (bib22) 2015; 9
Bilheimer, Goldstein, Grundy, Starzl, Brown (bib36) 1984; 311
Schmidt, Tietge, Buettner (bib4) 2008; 22
Stein, Dann, Wiegman (bib14) 2017; 70
Chacra, Ferrari, Rocha, Santos (bib23) 2019; 13
Raal, Pilcher, Panz (bib13) 2011; 124
Docherty, Padmanabhan (bib17) 2014
Rosada, Kassner, Banisch, Bender, Steinhagen-Thiessen, Vogt (bib31) 2016; 10
Hovingh, Davidson, Kastelein, O’Connor (bib21) 2013; 34
Parham, Goldberg (bib27) 2019; 20
Palacio, Harring, Nguyen, Goss, O’Mahony (bib1) 2011; 2011
Wiegman, Gidding, Watts (bib35) 2015; 36
Jiang, Gao, Hu (bib11) 2014; 177
Rader, Kastelein (bib16) 2014; 129
Rose, Wilson, Steiner (bib3) 1982; 100
Yu, Heere-Ress, Boucher (bib9) 1999; 146
Cuchel, Bruckert, Ginsberg (bib12) 2014; 35
Kayikcioglu, Kuman-Tuncel, Pirildar (bib32) 2019; 13
Luirink, Determeijer, Hutten (bib30) 2019; 13
Singh, Bittner (bib5) 2015; 17
Fogacci, Ferri, Toth, Ruscica, Corsini, Cicero (bib26) 2019; 79
Cephus, Qureshi, Sexson-Tejtel, Goss, Moodie (bib2) 2015; 10
(bib8) 1999
Nicholas, Otley, Taylor, Dhawan, Gilmore (bib34) 2010; 8
Kolansky, Cuchel, Clark (bib6) 2008; 102
Sanna, Stephenne, Revencu (bib15) 2016; 247
Maiorana, Nobili, Calandra (bib37) 2010; 15
Raal, Santos, Blom (bib24) 2010; 375
Martinez, Brodlie, Griesemer (bib7) 2016; 118
Najam, Ray (bib10) 2015; 4
Thomas, Cromwell, Ali, Chin, Flaim, Davidson (bib25) 2013; 62
Raal (10.1016/j.jacl.2019.09.007_bib19) 2015; 385
Kolansky (10.1016/j.jacl.2019.09.007_bib6) 2008; 102
Parham (10.1016/j.jacl.2019.09.007_bib27) 2019; 20
Santos (10.1016/j.jacl.2019.09.007_bib28) 2008; 197
Cephus (10.1016/j.jacl.2019.09.007_bib2) 2015; 10
Jiang (10.1016/j.jacl.2019.09.007_bib11) 2014; 177
Stein (10.1016/j.jacl.2019.09.007_bib14) 2017; 70
Singh (10.1016/j.jacl.2019.09.007_bib5) 2015; 17
Martinez (10.1016/j.jacl.2019.09.007_bib7) 2016; 118
Yu (10.1016/j.jacl.2019.09.007_bib9) 1999; 146
Hovingh (10.1016/j.jacl.2019.09.007_bib21) 2013; 34
Raal (10.1016/j.jacl.2019.09.007_bib13) 2011; 124
Bilheimer (10.1016/j.jacl.2019.09.007_bib36) 1984; 311
Raal (10.1016/j.jacl.2019.09.007_bib18) 2017; 5
Najam (10.1016/j.jacl.2019.09.007_bib10) 2015; 4
Sanna (10.1016/j.jacl.2019.09.007_bib15) 2016; 247
Rader (10.1016/j.jacl.2019.09.007_bib16) 2014; 129
Nicholas (10.1016/j.jacl.2019.09.007_bib34) 2010; 8
Maiorana (10.1016/j.jacl.2019.09.007_bib37) 2010; 15
Rose (10.1016/j.jacl.2019.09.007_bib3) 1982; 100
Gaudet (10.1016/j.jacl.2019.09.007_bib20) 2018; 12
Fogacci (10.1016/j.jacl.2019.09.007_bib26) 2019; 79
Rosada (10.1016/j.jacl.2019.09.007_bib31) 2016; 10
Parmar (10.1016/j.jacl.2019.09.007_bib33) 2017; 23
Wiegman (10.1016/j.jacl.2019.09.007_bib35) 2015; 36
Palacio (10.1016/j.jacl.2019.09.007_bib1) 2011; 2011
Schmidt (10.1016/j.jacl.2019.09.007_bib4) 2008; 22
Raal (10.1016/j.jacl.2019.09.007_bib24) 2010; 375
Chacra (10.1016/j.jacl.2019.09.007_bib23) 2019; 13
Luirink (10.1016/j.jacl.2019.09.007_bib29) 2019; 285
Roeters van Lennep (10.1016/j.jacl.2019.09.007_bib22) 2015; 9
Kayikcioglu (10.1016/j.jacl.2019.09.007_bib32) 2019; 13
Thomas (10.1016/j.jacl.2019.09.007_bib25) 2013; 62
Cuchel (10.1016/j.jacl.2019.09.007_bib12) 2014; 35
Docherty (10.1016/j.jacl.2019.09.007_bib17) 2014
Luirink (10.1016/j.jacl.2019.09.007_bib30) 2019; 13
References_xml – volume: 197
  start-page: 901
  year: 2008
  end-page: 915
  ident: bib28
  article-title: Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography
  publication-title: Atherosclerosis
  contributor:
    fullname: Martinez
– volume: 129
  start-page: 1022
  year: 2014
  end-page: 1032
  ident: bib16
  article-title: Lomitapide and Mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia
  publication-title: Circulation
  contributor:
    fullname: Kastelein
– volume: 375
  start-page: 998
  year: 2010
  end-page: 1006
  ident: bib24
  article-title: Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomized, double-blind, placebo-controlled trial
  publication-title: Lancet
  contributor:
    fullname: Blom
– volume: 20
  start-page: 127
  year: 2019
  end-page: 131
  ident: bib27
  article-title: Mipomersen and its use in familial hypercholesterolemia
  publication-title: Expert Opin Pharmacother
  contributor:
    fullname: Goldberg
– volume: 23
  start-page: 361
  year: 2017
  end-page: 374
  ident: bib33
  article-title: Health-related quality of life after pediatric liver transplantation: a systematic review
  publication-title: Liver Transplant
  contributor:
    fullname: Ng
– volume: 177
  start-page: 188
  year: 2014
  end-page: 191
  ident: bib11
  article-title: Seven-year clinical follow-up of a Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease – A need for early diagnosis and aggressive treatment
  publication-title: Int J Cardiol
  contributor:
    fullname: Hu
– volume: 34
  start-page: 962
  year: 2013
  end-page: 971
  ident: bib21
  article-title: Diagnosis and treatment of familial hypercholesterolemia
  publication-title: Eur Heart J
  contributor:
    fullname: O’Connor
– volume: 35
  start-page: 2146
  year: 2014
  end-page: 2157
  ident: bib12
  article-title: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
  publication-title: Eur Heart J
  contributor:
    fullname: Ginsberg
– volume: 102
  start-page: 1438
  year: 2008
  end-page: 1443
  ident: bib6
  article-title: Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia
  publication-title: Am J Cardiol
  contributor:
    fullname: Clark
– volume: 385
  start-page: 341
  year: 2015
  end-page: 350
  ident: bib19
  article-title: Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomized, double-blind, placebo-controlled trial
  publication-title: Lancet
  contributor:
    fullname: Blom
– volume: 12
  start-page: 1199
  year: 2018
  end-page: 1207
  ident: bib20
  article-title: Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: rational and design of the HAUSER-RCT study
  publication-title: J Clin Lipidol
  contributor:
    fullname: Gidding
– volume: 124
  start-page: 2202
  year: 2011
  end-page: 2207
  ident: bib13
  article-title: Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy
  publication-title: Circulation
  contributor:
    fullname: Panz
– volume: 247
  start-page: 97
  year: 2016
  end-page: 104
  ident: bib15
  article-title: Homozygous familial hypercholesterolemia in childhood: genotype-phenotype description, established therapies and perspectives
  publication-title: Atherosclerosis
  contributor:
    fullname: Revencu
– volume: 17
  start-page: 3
  year: 2015
  ident: bib5
  article-title: Familial hypercholesterolemia – epidemiology, diagnosis and screening
  publication-title: Curr Atheroscler Rep
  contributor:
    fullname: Bittner
– volume: 311
  start-page: 1658
  year: 1984
  end-page: 1664
  ident: bib36
  article-title: Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia
  publication-title: N Engl J Med
  contributor:
    fullname: Brown
– volume: 62
  start-page: 2178
  year: 2013
  end-page: 2184
  ident: bib25
  article-title: Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Davidson
– volume: 146
  start-page: 125
  year: 1999
  end-page: 131
  ident: bib9
  article-title: Familial hypercholesterolemia. Acceptor splice site (G -> C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R
  publication-title: Atherosclerosis
  contributor:
    fullname: Boucher
– volume: 10
  start-page: 323
  year: 2016
  end-page: 329
  ident: bib31
  article-title: Quality of life in patients treated with lipoprotein apheresis
  publication-title: J Clin Lipidol
  contributor:
    fullname: Vogt
– volume: 8
  start-page: 150
  year: 2010
  ident: bib34
  article-title: NgV. Experiences and barriers to health-related quality of life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents
  publication-title: Health Qual Life Outcomes
  contributor:
    fullname: Gilmore
– volume: 118
  start-page: 504
  year: 2016
  end-page: 510
  ident: bib7
  article-title: Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia
  publication-title: Am J Cardiol
  contributor:
    fullname: Griesemer
– volume: 13
  start-page: 31
  year: 2019
  end-page: 39
  ident: bib30
  article-title: Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: a systematic review
  publication-title: J Clin Lipidol
  contributor:
    fullname: Hutten
– year: 1999
  ident: bib8
  article-title: Familial Hypercholesterolemia: report of a second WHO consultation. Geneva 4 September 1998. World Health Organization
– volume: 2011
  start-page: 154908
  year: 2011
  ident: bib1
  article-title: Homozygous familial hypercholesterolemia: case series and review of the literature
  publication-title: Case Rep Transplant
  contributor:
    fullname: O’Mahony
– volume: 9
  start-page: 607
  year: 2015
  end-page: 617
  ident: bib22
  article-title: Treating homozygous familial hypercholesterolemia in a real-world setting: experiences with lomitapide
  publication-title: J Clin Lipidol
  contributor:
    fullname: Alonso
– volume: 70
  start-page: 1162
  year: 2017
  end-page: 1170
  ident: bib14
  article-title: Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Wiegman
– start-page: 715
  year: 2014
  end-page: 746
  ident: bib17
  article-title: Chaper 31:“Genomics and Pharmacogenomics of Lipid-Lowering Therapies”
  publication-title: Handbook of Pharmacogenomics and Stratified Medicine
  contributor:
    fullname: Padmanabhan
– volume: 22
  start-page: 180
  year: 2008
  end-page: 184
  ident: bib4
  article-title: Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation
  publication-title: Clin Transplant
  contributor:
    fullname: Buettner
– volume: 13
  start-page: 397
  year: 2019
  end-page: 401
  ident: bib23
  article-title: Case report: the efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child
  publication-title: J Clin Lipidol
  contributor:
    fullname: Santos
– volume: 79
  start-page: 751
  year: 2019
  end-page: 766
  ident: bib26
  article-title: Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials
  publication-title: Drugs
  contributor:
    fullname: Cicero
– volume: 100
  start-page: 757
  year: 1982
  end-page: 759
  ident: bib3
  article-title: Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling
  publication-title: J Pediatr
  contributor:
    fullname: Steiner
– volume: 5
  start-page: 280
  year: 2017
  end-page: 290
  ident: bib18
  article-title: Long-term treatment with evolocumab assed to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesteroleamia: an interim subset analysis of the open-label TAUSSIG study
  publication-title: Lancet Diabetes Endocrinol
  contributor:
    fullname: Blom
– volume: 36
  start-page: 2425
  year: 2015
  end-page: 2437
  ident: bib35
  article-title: Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
  publication-title: Eur Heart J
  contributor:
    fullname: Watts
– volume: 285
  start-page: 87
  year: 2019
  end-page: 92
  ident: bib29
  article-title: Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia
  publication-title: Atherosclerosis
  contributor:
    fullname: Hutten
– volume: 15
  start-page: E25
  year: 2010
  end-page: E29
  ident: bib37
  article-title: Preemptive liver transplantation in a child with familial hypercholesterolemia
  publication-title: Pediatr Transplant
  contributor:
    fullname: Calandra
– volume: 13
  start-page: 455
  year: 2019
  end-page: 467
  ident: bib32
  article-title: Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: results of a nationwide survey (A-HIT1 registry)
  publication-title: J Clin Lipidol
  contributor:
    fullname: Pirildar
– volume: 4
  start-page: 25
  year: 2015
  end-page: 38
  ident: bib10
  article-title: Familial hypercholesterolemia: a review of the natural history, diagnosis and management
  publication-title: Cardiol Ther
  contributor:
    fullname: Ray
– volume: 10
  start-page: 520
  year: 2015
  end-page: 528
  ident: bib2
  article-title: Liver transplantation for HoFH in children: single center experience
  publication-title: Congenit Heart Dis
  contributor:
    fullname: Moodie
– volume: 8
  start-page: 150
  year: 2010
  ident: 10.1016/j.jacl.2019.09.007_bib34
  article-title: NgV. Experiences and barriers to health-related quality of life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-8-150
  contributor:
    fullname: Nicholas
– volume: 197
  start-page: 901
  year: 2008
  ident: 10.1016/j.jacl.2019.09.007_bib28
  article-title: Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.08.017
  contributor:
    fullname: Santos
– volume: 12
  start-page: 1199
  year: 2018
  ident: 10.1016/j.jacl.2019.09.007_bib20
  article-title: Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: rational and design of the HAUSER-RCT study
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2018.05.007
  contributor:
    fullname: Gaudet
– volume: 13
  start-page: 397
  year: 2019
  ident: 10.1016/j.jacl.2019.09.007_bib23
  article-title: Case report: the efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2019.03.001
  contributor:
    fullname: Chacra
– volume: 22
  start-page: 180
  year: 2008
  ident: 10.1016/j.jacl.2019.09.007_bib4
  article-title: Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation
  publication-title: Clin Transplant
  doi: 10.1111/j.1399-0012.2007.00764.x
  contributor:
    fullname: Schmidt
– volume: 102
  start-page: 1438
  year: 2008
  ident: 10.1016/j.jacl.2019.09.007_bib6
  article-title: Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2008.07.035
  contributor:
    fullname: Kolansky
– volume: 34
  start-page: 962
  year: 2013
  ident: 10.1016/j.jacl.2019.09.007_bib21
  article-title: Diagnosis and treatment of familial hypercholesterolemia
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/eht015
  contributor:
    fullname: Hovingh
– volume: 13
  start-page: 31
  year: 2019
  ident: 10.1016/j.jacl.2019.09.007_bib30
  article-title: Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: a systematic review
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2018.10.011
  contributor:
    fullname: Luirink
– volume: 13
  start-page: 455
  year: 2019
  ident: 10.1016/j.jacl.2019.09.007_bib32
  article-title: Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: results of a nationwide survey (A-HIT1 registry)
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2019.02.001
  contributor:
    fullname: Kayikcioglu
– volume: 118
  start-page: 504
  year: 2016
  ident: 10.1016/j.jacl.2019.09.007_bib7
  article-title: Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2016.05.042
  contributor:
    fullname: Martinez
– volume: 10
  start-page: 520
  issue: 6
  year: 2015
  ident: 10.1016/j.jacl.2019.09.007_bib2
  article-title: Liver transplantation for HoFH in children: single center experience
  publication-title: Congenit Heart Dis
  doi: 10.1111/chd.12301
  contributor:
    fullname: Cephus
– volume: 129
  start-page: 1022
  year: 2014
  ident: 10.1016/j.jacl.2019.09.007_bib16
  article-title: Lomitapide and Mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.001292
  contributor:
    fullname: Rader
– volume: 70
  start-page: 1162
  issue: 9
  year: 2017
  ident: 10.1016/j.jacl.2019.09.007_bib14
  article-title: Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2017.06.058
  contributor:
    fullname: Stein
– volume: 5
  start-page: 280
  year: 2017
  ident: 10.1016/j.jacl.2019.09.007_bib18
  article-title: Long-term treatment with evolocumab assed to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesteroleamia: an interim subset analysis of the open-label TAUSSIG study
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(17)30044-X
  contributor:
    fullname: Raal
– volume: 62
  start-page: 2178
  year: 2013
  ident: 10.1016/j.jacl.2019.09.007_bib25
  article-title: Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.07.081
  contributor:
    fullname: Thomas
– volume: 10
  start-page: 323
  year: 2016
  ident: 10.1016/j.jacl.2019.09.007_bib31
  article-title: Quality of life in patients treated with lipoprotein apheresis
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2015.12.009
  contributor:
    fullname: Rosada
– volume: 23
  start-page: 361
  year: 2017
  ident: 10.1016/j.jacl.2019.09.007_bib33
  article-title: Health-related quality of life after pediatric liver transplantation: a systematic review
  publication-title: Liver Transplant
  doi: 10.1002/lt.24696
  contributor:
    fullname: Parmar
– volume: 15
  start-page: E25
  year: 2010
  ident: 10.1016/j.jacl.2019.09.007_bib37
  article-title: Preemptive liver transplantation in a child with familial hypercholesterolemia
  publication-title: Pediatr Transplant
  contributor:
    fullname: Maiorana
– volume: 285
  start-page: 87
  year: 2019
  ident: 10.1016/j.jacl.2019.09.007_bib29
  article-title: Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2019.04.219
  contributor:
    fullname: Luirink
– start-page: 715
  year: 2014
  ident: 10.1016/j.jacl.2019.09.007_bib17
  article-title: Chaper 31:“Genomics and Pharmacogenomics of Lipid-Lowering Therapies”
  contributor:
    fullname: Docherty
– volume: 2011
  start-page: 154908
  year: 2011
  ident: 10.1016/j.jacl.2019.09.007_bib1
  article-title: Homozygous familial hypercholesterolemia: case series and review of the literature
  publication-title: Case Rep Transplant
  contributor:
    fullname: Palacio
– volume: 79
  start-page: 751
  issue: 7
  year: 2019
  ident: 10.1016/j.jacl.2019.09.007_bib26
  article-title: Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials
  publication-title: Drugs
  doi: 10.1007/s40265-019-01114-z
  contributor:
    fullname: Fogacci
– volume: 311
  start-page: 1658
  year: 1984
  ident: 10.1016/j.jacl.2019.09.007_bib36
  article-title: Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198412273112603
  contributor:
    fullname: Bilheimer
– volume: 177
  start-page: 188
  year: 2014
  ident: 10.1016/j.jacl.2019.09.007_bib11
  article-title: Seven-year clinical follow-up of a Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease – A need for early diagnosis and aggressive treatment
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2014.09.058
  contributor:
    fullname: Jiang
– volume: 20
  start-page: 127
  issue: 2
  year: 2019
  ident: 10.1016/j.jacl.2019.09.007_bib27
  article-title: Mipomersen and its use in familial hypercholesterolemia
  publication-title: Expert Opin Pharmacother
  doi: 10.1080/14656566.2018.1550071
  contributor:
    fullname: Parham
– volume: 4
  start-page: 25
  issue: 1
  year: 2015
  ident: 10.1016/j.jacl.2019.09.007_bib10
  article-title: Familial hypercholesterolemia: a review of the natural history, diagnosis and management
  publication-title: Cardiol Ther
  doi: 10.1007/s40119-015-0037-z
  contributor:
    fullname: Najam
– volume: 146
  start-page: 125
  year: 1999
  ident: 10.1016/j.jacl.2019.09.007_bib9
  article-title: Familial hypercholesterolemia. Acceptor splice site (G -> C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-RHonduras-1 [LDL-R1061( -1) G -> C]
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(99)00109-4
  contributor:
    fullname: Yu
– volume: 9
  start-page: 607
  year: 2015
  ident: 10.1016/j.jacl.2019.09.007_bib22
  article-title: Treating homozygous familial hypercholesterolemia in a real-world setting: experiences with lomitapide
  publication-title: J Clin Lipidol
  doi: 10.1016/j.jacl.2015.05.001
  contributor:
    fullname: Roeters van Lennep
– volume: 247
  start-page: 97
  year: 2016
  ident: 10.1016/j.jacl.2019.09.007_bib15
  article-title: Homozygous familial hypercholesterolemia in childhood: genotype-phenotype description, established therapies and perspectives
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2016.02.009
  contributor:
    fullname: Sanna
– volume: 17
  start-page: 3
  year: 2015
  ident: 10.1016/j.jacl.2019.09.007_bib5
  article-title: Familial hypercholesterolemia – epidemiology, diagnosis and screening
  publication-title: Curr Atheroscler Rep
  doi: 10.1007/s11883-014-0482-5
  contributor:
    fullname: Singh
– volume: 35
  start-page: 2146
  issue: 32
  year: 2014
  ident: 10.1016/j.jacl.2019.09.007_bib12
  article-title: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehu274
  contributor:
    fullname: Cuchel
– volume: 375
  start-page: 998
  year: 2010
  ident: 10.1016/j.jacl.2019.09.007_bib24
  article-title: Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomized, double-blind, placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60284-X
  contributor:
    fullname: Raal
– volume: 124
  start-page: 2202
  year: 2011
  ident: 10.1016/j.jacl.2019.09.007_bib13
  article-title: Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.042523
  contributor:
    fullname: Raal
– volume: 36
  start-page: 2425
  issue: 36
  year: 2015
  ident: 10.1016/j.jacl.2019.09.007_bib35
  article-title: Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehv157
  contributor:
    fullname: Wiegman
– volume: 100
  start-page: 757
  issue: 5
  year: 1982
  ident: 10.1016/j.jacl.2019.09.007_bib3
  article-title: Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(82)80579-9
  contributor:
    fullname: Rose
– volume: 385
  start-page: 341
  year: 2015
  ident: 10.1016/j.jacl.2019.09.007_bib19
  article-title: Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomized, double-blind, placebo-controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61374-X
  contributor:
    fullname: Raal
SSID ssj0055705
Score 2.294655
Snippet Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease. Current medical...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 880
SubjectTerms Angiogram
Cardiac catheterization
Coronary atherosclerosis
Genetic
LDL receptor
Liver transplantation
Pediatric
Regression
Treatment
Title Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation
URI https://dx.doi.org/10.1016/j.jacl.2019.09.007
https://www.ncbi.nlm.nih.gov/pubmed/31704104
https://search.proquest.com/docview/2313358086
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LS8MwGA9DL15E8TUfI4I3qWubJmu9jeGYih58wG4hTVKdzE5GBefBv93vS1pBUA9CIbT0EX5f-j3yvQg54qmIjBVZoEB4BolJVJCBIAgKbaKMawVKMyY4X12L0X1yMebjFhk0uTAYVlnzfs_THbeur3RrNLsvk0n3FlQPhtXaYQTbKhtjBjsPsYvBycdXmAdWmOLes8wCvLtOnPExXk9Ko_shylytU2wp-7Nw-k35dEJouEZWa-2R9v0E10nLlhvkbYBVCNR8QV185oLWThc6KamiLlub4nYrfZw9z94XD2DrU7evAUuPPoIdOkcW6ComwPA8Uaf0xj74-Fh4AzYRp1MM36CVq4Q-VT5dqdwk98Ozu8EoqBsqBJpxUQV5IQqbRUoAcEzoHOhThDYCqMEKYRYsH5aJ2DAtWGF0mGjGuIlik0ZF0Qt7OdsiS-WstDuEAh11Gpo0xdTURDGVA6MwcVIwwbWNeZscN0jKF183QzYBZU8ScZeIuwzhCHttwhuw5TfqS2Dsfz532FBGwm-Bvg5VWoBRgtrK0MObijbZ9iT7mgeoTGECZujuP7-6R1bwzGck7pOlav5qD0A1qfKOW3sdstw_vxxdfwI0c-Ts
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA5VD3oRxVd9RvAma3ebTbrrTYqlPg_aQm8hm2RrRbdSKlgP_nZnkl1BUA_CQmCf4Zvs5JvMI4Qc8URExoo0UDB5BrGJVZDCRBDk2kQp1wpIMyY439yKbj--HPBBjbSrXBgMqyx1v9fpTluXZxolmo2X0ahxD9SDYbV2aMG2SgdzZCHmwH5hUJ98fMV5YIkp7l3LLMDby8wZH-T1qDT6H6LUFTvFPWV_np1-Y59uFuqskOWSPtIz38NVUrPFGnlrYxkCNZlRF6A5o6XXhY4KqqhL16a43kofxs_j99kQjH3qFjZg7NEHMEQnqANdyQRonkfqlN7ZoQ-QhTfgLuL0CeM36NSVQn9SPl-pWCf9znmv3Q3KHRUCzbiYBlkucptGSgByTOgMBJSHNgKswQxhFkwfloqmYVqw3Ogw1oxxEzVNEuV5K2xlbIPMF-PCbhEKgtRJaJIEc1NjxVQGmsI045wJrm2T18lxhaR88YUzZBVR9igRd4m4yxCOsFUnvAJbfhO_BM3-53OHlWQk_Bfo7FCFBRgl8FaGLt5E1MmmF9lXP4AzhTHYodv__OoBWez2bq7l9cXt1Q5Zwis-PXGXzE8nr3YPeMo023fj8BOoKuaJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+artery+disease+in+a+child+with+homozygous+familial+hypercholesterolemia%3A+Regression+after+liver+transplantation&rft.jtitle=Journal+of+clinical+lipidology&rft.au=Cephus%2C+Constance+E&rft.au=Qureshi%2C+Athar+M&rft.au=Sexson+Tejtel%2C+S+Kristen&rft.au=Alam%2C+Mahboob&rft.date=2019-11-01&rft.issn=1933-2874&rft.volume=13&rft.issue=6&rft.spage=880&rft_id=info:doi/10.1016%2Fj.jacl.2019.09.007&rft_id=info%3Apmid%2F31704104&rft.externalDocID=31704104
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-2874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-2874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-2874&client=summon